In Brief Cancer Support Community adds Digital Nonprofit MyLifeLine to its network February 02, 2018Vol.44 No.05
Conversation with The Cancer Letter Miller: “Doctors and patients have confidence in knowing that a test has gone through FDA” February 02, 2018Vol.44 No.05By Paul Goldberg
Dear CMS, Here’s what I think about your NGS policy…Agency draft memo garners 315 comments February 02, 2018Vol.44 No.05By Paul Goldberg
Like it or not, CMS policy aims to change everything in Next generation sequencing February 02, 2018Vol.44 No.05By Paul Goldberg
Liquid biopsy results differed substantially between two providers in a study December 29, 2017Vol.40 No.11
Aggressive surgery is best treatment option for early stage lung cancer December 29, 2017Vol.40 No.11
Galera Therapeutics reports statistically significant results in a 223-patient phase IIb trial of GC4419 for oral mucositis in head and neck cancer December 29, 2017Vol.40 No.11
PD-1 antibody cemiplimab demonstrates 46.3% ORR in advanced cutaneous squamous cell carcinoma December 29, 2017Vol.40 No.11
